InspireMD to Present at the 23rd Annual Needham Virtual Healthcare ConferenceGlobeNewswireApril 03, 2024TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard(TM) Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Marvin Slosman, Chief Executive Officer, will deliver a company update presentation at the 23rd Annual Needham Virtual Healthcare Conference, which is being held April 8-11, 2024.
Presentation details:
Date:Wednesday, April 10thTime:8:00-8:40 AM ETWebcast:https://wsw.com/webcast/needham138/nspr/2290730, or on the Events section of the company's Investor Relations website at https://www.inspiremd.com/en/events/.About InspireMD, Inc.InspireMD seeks to utilize its proprietary MicroNet(R) technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD's common stock is quoted on the Nasdaq under the ticker symbol NSPR.
We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Investor Contacts:
Craig ShoreChief Financial OfficerInspireMD, Inc.888-776-6804craigs@inspiremd.com
Chuck Padala, Managing DirectorLifeSci Advisors646-627-8390chuck@lifesciadvisors.cominvestor-relations@inspiremd.com
COMTEX_450276567/2010/2024-04-03T08:59:42
TEL AVIV, Israel and MIAMI, April 03, 2024 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard(TM) Embolic Prevention Stent System (EPS) for the prevention of stroke, today announced that Marvin Slosman, Chief Executive Officer, will deliver a company update presentation at the 23rd Annual Needham Virtual Healthcare Conference, which is being held April 8-11, 2024.
Presentation details:
Date:Wednesday, April 10thTime:8:00-8:40 AM ETWebcast:https://wsw.com/webcast/needham138/nspr/2290730, or on the Events section of the company's Investor Relations website at https://www.inspiremd.com/en/events/.About InspireMD, Inc.InspireMD seeks to utilize its proprietary MicroNet(R) technology to make its products the industry standard for carotid stenting by providing outstanding acute results and durable, stroke-free long-term outcomes. InspireMD's common stock is quoted on the Nasdaq under the ticker symbol NSPR.
We routinely post information that may be important to investors on our website. For more information, please visit www.inspiremd.com.
Investor Contacts:
Craig ShoreChief Financial OfficerInspireMD, Inc.888-776-6804craigs@inspiremd.com
Chuck Padala, Managing DirectorLifeSci Advisors646-627-8390chuck@lifesciadvisors.cominvestor-relations@inspiremd.com
COMTEX_450276567/2010/2024-04-03T08:59:42
0.50% $0.01
